Premium
Cutaneous Mycobacterium kansasii infection—treatment with erythromycin
Author(s) -
GROVES R.W.,
NEWTON J.A.,
HAY R.J.
Publication year - 1991
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/j.1365-2230.1991.tb00382.x
Subject(s) - mycobacterium kansasii , erythromycin , mycobacterium avium complex , medicine , microbiology and biotechnology , dermatology , mycobacterium , antibiotics , immunology , biology , pathology , tuberculosis
Summary A 20‐year‐old woman developed cutaneous Mycobacterium kansasii infection following steroid infiltration of two plaques of lichen simplex. The organism was resistant to many standard antituberculous drugs and following sensitivity studies treatment with erythromycin was begun. This has been effective and well tolerated. Treatment of atypical mycobacteria with drugs not traditionally associated with antituberculous activity is being increasingly reported and, so far, resistance has not been a problem. Erythromycin has good tissue penetration with excellent activity against M. kansasii and should be considered in the therapy of similar cases.